Effect of spironolactone in hypertensive patients.
D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000150:complications; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001806:Blood Urea Nitrogen; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy*; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D012083:Renin / Q000097:blood; D012964:Sodium / Q000097:blood; D013148:Spironolactone / Q000009:adverse effects / Q000627:therapeutic use*; D014527:Uric Acid / Q000097:blood
D000959:Antihypertensive Agents; D014527:Uric Acid; D013148:Spironolactone; D012964:Sodium; D012083:Renin; D011188:Potassium